Equities

Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)44.64
  • Today's Change-0.82 / -1.80%
  • Shares traded666.19k
  • 1 Year change-21.51%
  • Beta0.7958
Data delayed at least 15 minutes, as of Nov 25 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue644499438
OPERATING EXPENSES
Cost of revenue total291250238
Selling, general and admin. expenses, total806769
Depreciation/amortization9.851011
Unusual expense(income)5.705.40(14)
Other operating expenses, total------
Total operating expense450397354
Operating income19410283
Other, net(3.93)140.94
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes17111684
Provision for income taxes322321
Net income after taxes1409364
Minority interest--0(1.19)
Net income before extra. Items1389162
Total extraordinary items------
Net income1389162
Inc.avail. to common excl. extra. Items1389162
Inc.avail. to common incl. extra. Items1389162
EPS RECONCILIATION
Basic/primary weighted average shares484948
Basic/primary eps excl. extra items2.851.881.30
Basic/primary eps incl. extra items2.851.881.30
Dilution adjustment------
Diluted weighted average shares535250
Diluted eps excl. extra items2.601.741.25
Diluted eps incl. extra items2.601.741.25
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental241.850.89
SUPPLEMENTAL INCOME
Depreciation, supplemental252423
Total special items5.705.40(14)
NORMALISED INCOME
Normalized income before taxes17712171
Effect of special items on income taxes1.061.09(3.33)
Income tax excluding impact of special items332517
Normalized income after tax1449753
Normalized income avail. to common1429652
Basic normalized EPS2.951.971.09
Diluted normalized EPS2.681.831.04
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.